166 Results for "

Transmembrane domain

" in MedChemExpress (MCE) Product Catalog:
Products (166)

166 Results for "Transmembrane domain" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-113329
CAS No.: 543-18-0
Purity:  ≥98.0%
Synonyms: Taurocyamine
Guanidinoethyl sulfonate (Taurocyamine) is an orally available, blood-brain permeable competitive inhibitor of taurine transporters and a competitive antagonist of glycine receptors (GlyR) (IC50=565 μM). Guanidinoethyl sulfonate has both weak agonist and antagonist effects on GABAA receptors. Guanidinoethyl sulfonate inhibits taurine transmembrane transport and competitively binds to the GlyR ligand binding domain, thereby blocking glycine-mediated chloride influx, and may regulate brain pH to exert neuroprotective effects. Guanidinoethyl sulfonate can be used for neuroprotection studies of ischemic brain injury .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-135542
CAS No.: 184241-44-9
Purity:  99.94%
Target:  

CRFR

Research Areas:  

Others

NBI-27914 is a highly selective, high-affinity non-peptide competitive antagonist of human corticotropin-releasing factor receptor 1 (CRFR1). NBI-27914 primarily binds to the His199 and Met276 sites in the transmembrane domain of the receptor .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135416
CAS No.: 98072-47-0
Streptolysin O is a cholesterol-targeting, thiol-activated pore-forming toxin. Streptolysin O binds to cholesterol via its C-terminal domain 4, oligomerizes to form arc-shaped or ring-shaped structures, inserts amphipathic helices into the lipid bilayer, and forms transmembrane β-barrel pores, resulting in cell permeabilization. Streptolysin O enables controllable cell membrane permeabilization, fluorescent probe delivery, and exogenous molecule uptake .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13242
CAS No.: 1258861-20-9
Purity:  99.92%
Synonyms: LY2940680
Target:  

Smo Gli

Research Areas:  

Cancer

Taladegib is a Smoothened (SMO) antagonist. Taladegib hydrochloride inhibits the Hedgehog signaling pathway, with an IC50 of 5.5 nM for suppressing GLI1 mRNA expression in DAOY cells and an IC50 of 7.6 nM in CGNP cell proliferation assays. Taladegib binds to the extracellular loop region (site 1) of the transmembrane domain of the SMO receptor, competes with cyclopamine for SMO binding, and thereby inhibits Gli-dependent transcription. Taladegib can be used in studies of Hedgehog pathway-related cancers .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-156095
CAS No.: 897109-93-2
Purity:  99.42%
Target:  

Wnt

Research Areas:  

Cancer

F7H is a Frizzled receptor FZD7 antagonist (IC50: 1.25 μM). Frizzled receptors (FZDs) influence Wnt signaling, mediating embryonic development and tissue homeostasis. F7H is a potent ligand for the FZD7 transmembrane domain (TMD) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1925A
CAS No.: 1222186-26-6
Research Areas:  

Cancer

GO-203 TFA is a potent MUC1-C oncoprotein inhibitor. GO-203 TFA is an all D-amino acid peptide that consists of a poly-R transduction domain linked to a CQCRRKN motif that binds to the MUC1-C cytoplasmic tail and blocks MUC1-C homodimerization. GO-203 TFA downregulates TIGAR (TP53-induced glycolysis and apoptosis regulator) protein synthesis by inhibiting the PI3K-AKT-S6K1 pathway. GO-203 TFA induces the production of ROS and loss of mitochondrial transmembrane potential. GO-203 TFA inhibits the growth of colon cancer cells in vitro and as xenografts in nude mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-157214
CAS No.: 3030588-01-0
Purity:  99.76%
Target:  

STING Molecular Glues

Research Areas:  

Cancer

NVS-STG2 is a molecular glue that targets STINGtransmembrane domains, effectively acting as a molecular glue. NVS-STGI enhances the activity of cGAMP by inducing the formation of more abundant and larger oligomers. NVS-STG2 produces antitumor activity in animal models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103565
CAS No.: 97075-46-2
Purity:  99.83%
Target:  

mGluR

Research Areas:  

Neurological Disease

AMN082, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135416A
CAS No.: 98072-47-0
Purity:  ≥96.0%
Recombinant Streptolysin O is a cholesterol-targeting, thiol-activated pore-forming toxin. Recombinant Streptolysin O binds to cholesterol via its C-terminal domain 4, oligomerizes to form arc-shaped or ring-shaped structures, inserts amphipathic helices into the lipid bilayer, and forms transmembrane β-barrel pores, resulting in cell permeabilization. Recombinant Streptolysin O enables controllable cell membrane permeabilization, fluorescent probe delivery, and exogenous molecule uptake .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103565A
CAS No.: 83027-13-8
Purity:  98.37%
Target:  

mGluR

Research Areas:  

Neurological Disease

AMN082 free base, a selective, orally active, and brain penetrant mGluR7 agonist, directly activates receptor signaling via an allosteric site in the transmembrane domain. AMN082 free base potently inhibits cAMP accumulation and stimulates GTPγS binding (EC50 values, 64-290 nM) at transfected mammalian cells expressing mGluR7. AMN082 free base shows selectivity over other mGluR subtypes and selected ionotropic glutamate receptors. Antidepressant effects .
loading...
    loading...
Cat. No.: HY-P1985
CAS No.: 2408730-51-6
Target:  

Notch

Research Areas:  

Cardiovascular Disease Cancer

Notch 1 (Notch homolog 1, translocation-associated) can encode a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types .
loading...
    loading...
Cat. No.: HY-119165
CAS No.: 884600-68-4
Purity:  98.39%
Target:  

γ-secretase

Research Areas:  

Neurological Disease

GSM-1 is a potent γ-secretase modulator. GSM-1 directly targets the transmembrane domain (TMD) 1 of presenilin 1 (PS1) .
loading...
    loading...
Cat. No.: HY-P2508
CAS No.: 149205-73-2
Target:  

Mucin

Research Areas:  

Cancer

MUC1, mucin core is the region of the MUC1 mucin core. MUC1 is a type I transmembrane glycoprotein, and is overexpressed and aberrantly glycosylated in carcinoma cells. MUC1, mucin core protein binds to domain 1 of ICAM-1 .
loading...
    loading...
Cat. No.: HY-111163
CAS No.: 908563-68-8
Purity:  98.74%
Target:  

Apoptosis

Research Areas:  

Cancer

NSC49652 is a reversible, orally active p75 neurotrophin receptor (p75 NTR, also known as NGFR, TNFRSF16, and CD271) agonist. NSC49652 targets the transmembrane domain of p75 NTR. NSC49652 induces apoptosis and affects the viability of melanoma cells .
loading...
    loading...
Cat. No.: HY-150407
CAS No.: 4560-08-1
Purity:  ≥98.0%
TSPO ligand-1 is the ligand of AUTAC4 (HY-134640) that can be used in the synthesis of PROTACs. TSPO ligand-1 is a mitochondrial outer membrane transmembrane structural domain protein can bind to AUTAC4 and regulate mitochondrial autophagy to promote targeted mitochondrial renewal. TSPO ligand-1 is also involved in the transport of cholesterol from the outer to inner mitochondrial membrane and serves as a sensitive biomarker of brain injury and neurodegeneration .
loading...
    loading...
Cat. No.: HY-P10495A
Target:  

Peptides

Research Areas:  

Cancer

GPR110 peptide agonist P12 acetate is the acetate salt form of GPR110 peptide agonist P12 (HY-P10495). GPR110 peptide agonist P12 acetateis a peptide that acts as a GPR110 agonist. GPR110 peptide agonist P12 acetate can significantly enhance the initial rate of GPR110 stimulated G protein GTPγS binding. GPR110 peptide agonist P12 acetate mimics the action of natural ligands, causing the extracellular domain (ECD) of the GPR110 to dissociate from the seven transmembrane domains (7TM), exposing the β-strand-13/stalk region at the N-terminus of the 7TM domain, which acts as an agonist to activate G protein signaling. GPR110 peptide agonist P12 acetate can be used in the study of developmental disorders and cancers related to GPR110 .
loading...
    loading...
Cat. No.: HY-119229
CAS No.: 815592-21-3
Target:  

CFTR

Research Areas:  

Inflammation/Immunology

VRT-325 is a CFTR modulator. VRT-325 inhibits disulfide cross-linking between cysteines in transmembrane segments 6 and 7 of CFTR and P-gp. VRT-325 promotes maturation of CFTR and P-gp processing mutants, rescues ΔF508-CFTR folding at the endoplasmic reticulum. VRT-325 binds ΔF508-CFTR nucleotide-binding domain 1, and increases mature ΔF508-CFTR cell surface expression and chloride conductance. VRT-325 can be used for the research of cystic fibrosis [1] [3].
loading...
    loading...
Cat. No.: HY-129527
CAS No.: 2315311-83-0
Purity:  99.91%
Target:  

iGluR

Research Areas:  

Neurological Disease

GNE-9278 is a highly selective positive allosteric modulator of NMDAR that acts at the GluN1 transmembrane domain (TMD). GNE-9278 acts on activated NMDARs to increase peak current and agonist affinity .
loading...
    loading...
Cat. No.: HY-178234
CAS No.: 1892576-07-6
Target:  

GPR84

Research Areas:  

Inflammation/Immunology

LY237 is a potent GPR84 full agonist, with EC50 values of 0.189 nM and 0.07 nM in cAMP inhibition assay and calcium flux assay, respectively. LY237 binds to the amphipathic orthosteric pocket of GPR84, stabilizes the active conformation of the receptor, and promotes its coupling with Gαi protein. LY237 can be used in research related to ulcerative colitis, fibrotic diseases, non-alcoholic steatohepatitis, and acute respiratory distress syndrome .
loading...
    loading...
Cat. No.: HY-P10716
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Exendin-P5 is a selective agonist that targets the GLP-1R. Exendin-P5 promotes rapid activation of G proteins by transient interactions with the transmembrane domain of GLP-1R, enhancing its potency in G protein-mediated signaling and accelerating cAMP production. This mechanism suggests the potential application of Exendin-P5 in the study of metabolic diseases .
loading...
    loading...